Salt Restriction and Challenges in China for Hypertension Control

详细信息    查看全文

• 作者：Li Yan (1)
  Nicole Li (2)
  Yangfeng Wu (1) (2)
  
• 关键词：Salt ; Salt substitute ; Hypertension ; Blood pressure ; China
• 刊名：Current Cardiovascular Risk Reports
• 出版年：2011
• 出版时间：April 2011
• 年：2011
• 卷：5
• 期：2
• 页码：180-186
• 全文大小：140KB
• 参考文献：1. World Health Organization. World Health Statistics 2006. Geneva: World Health Organization; 2006.
  2. China Ministry of Health. 2010 Annual Report on Health Statistics. Beijing: Peking Union Medical College Publishing House; 2010.
  3. World Health Organization. Preventing chronic diseases: A vital investment: A WHO Report. In. Geneva, Switzerland: World Health Organization; 2005.
  4. Ezzati M, Vander Hoorn S, Lawes CMM, et al. Rethinking the “diseases of affluence-paradigm: global patterns of nutritional risks in relation to economic development. PLoS Med. 2005;2:404-2. CrossRef
  5. Burden of Disease/Comparative Risk Assessment. Available at: http://files.dcp2.org/pdf/expressbooks/burdeno.pdf. Accessed December 2010.
  6. Ezzati M, Lopez AD, Rodgers A, et al. Selected major risk factors and global and regional burden of disease. Lancet. 2002;360:1347-0. CrossRef
  7. Kearney PM, Whelton M, Reynolds K, et al. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365:217-3.
  8. Egan BM, Zhao Y, Axon RN. US trends in prevalence, awareness, treatment, and control of hypertension, 1988-008. JAMA. 2010;303:2043-0. CrossRef
  9. Lane DA, Lip GY. Ethnic differences in hypertension and blood pressure control in the UK. QJM. 2001;94:391-. CrossRef
  10. Wolf-Maier K, Cooper RS, Kramer H, et al. Hypertension treatment and control in five European countries, Canada, and the United States. Hypertension. 2004;43:10-. CrossRef
  11. Nissinen A, Berrios X, Puska P. Community-based noncommunicable disease interventions: lessons from developed countries for developing ones. Bull World Health Organ. 2001;79:963-0.
  12. Pereira M, Lunet N, Azevedo A, et al. Differences in prevalence, awareness, treatment and control of hypertension between developing and developed countries. J Hypertens. 2009;27:963-5. CrossRef
  13. Mori H, Ukai H, Yamamoto H, et al. Current status of antihypertensive prescription and associated blood pressure control in Japan. Hypertens Res. 2006;29:143-1. CrossRef
  14. Iso H, Shimamoto T, Naito Y, et al. Effects of a long-term hypertension control program on stroke incidence and prevalence in a rural community in northeastern Japan. Stroke. 1998;29:1510-.
  15. Wang L. Nutrition and health status in Chinese people. Beijing: People’s Publishing House; 2005.
  16. Tao S, Wu X, Duan X, et al. Hypertension prevalence and status of awareness, treatment and control in China. Chin Med J Engl. 1995;108:483-.
  17. Wu Y, Huxley R, Li L, et al. Prevalence, awareness, treatment, and control of hypertension in China: data from the China National Nutrition and Health Survey 2002. Circulation. 2008;118:2679-6. CrossRef
  18. Intersalt Cooperative Research Group. Intersalt: an international study of electrolyte excretion and blood pressure. Results for 24 hour urinary sodium and potassium excretion. Intersalt Cooperative Research Group. BMJ. 1988;297:319-8. CrossRef
  19. Elliott P, Stamler J, Nichols R, et al. Intersalt revisited: further analyses of 24 hour sodium excretion and blood pressure within and across populations. Br Med J. 1996;312:1249-3.
  20. Stamler J, Elliott P, Dennis B, et al. INTERMAP: background, aims, design, methods, and descriptive statistics (nondietary). J Hum Hypertens. 2003;17:591-08. CrossRef
  21. Zhou BF, Stamler J, Dennis B, et al. Nutrient intakes of middle-aged men and women in China, Japan, United Kingdom, and United States in the late 1990s: the INTERMAP study. J Hum Hypertens. 2003;17:623-0. CrossRef
  22. Zhao LC, Stamler J, Yan LJL, et al. Blood pressure differences between northern and southern Chinese: role of dietary factors the international study on macronutrients and blood pressure. Hypertension. 2004;43:1332-. CrossRef
  23. Nagata C, Takatsuka N, Shimizu N, et al. Sodium intake and risk of death from stroke in Japanese men and women. Stroke. 2004;35:1543-. CrossRef
  24. Sacks FM, Svetkey LP, Vollmer WM, et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med. 2001;344:3-0. CrossRef
  25. The Trials of Hypertension Prevention Cooperative Research Group. The effects of nonpharmacologic interventions on blood pressure of persons with high normal levels. Results of the trials of hypertension prevention, Phase I. JAMA. 1992;267:1213-0. CrossRef
  26. Stevens VJ, Obarzanek E, Cook NR, et al. Long-term weight loss and changes in blood pressure: results of the trials of hypertension prevention, phase II. Ann Intern Med. 2001;134:1-1.
  27. He FJ, MacGregor GA. Effect of longer-term modest salt reduction on blood pressure. Cochrane Database of Syst Rev. 2004; CD004937.
  28. Cook NR, Cutler JA, Obarzanek E, et al. Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP). BMJ. 2007;334:885-. CrossRef
  29. Gelejinske J. Reduction in blood pressure with a low sodium, high potassium, high magnesium salt in older subjects with mild to moderate hypertension. BMJ. 1994;309:456-.
  30. Kawasaki T, Itoh K, Kawasaki M. Reduction in blood pressure with a sodium-reduced, potassium- and magnesium-enriched mineral salt in subjects with mild essential hypertension. Hypertens Res Clin Exp. 1998;21:235-3. CrossRef
  31. Li NY, Wu Y, Barzi F, et al. A low sodium, high potassium salt substitute substantially lowers blood pressure levels among high-risk individuals in rural northern China—The China salt substitute study. J Hypertens. 2006;24:S150-.
  32. China Salt Substitute Study Collaborative Group. Salt substitution: a low-cost strategy for blood pressure control among rural Chinese. A randomized, controlled trial. J Hypertens. 2007;25:2011-. CrossRef
  33. -Hu J, Jiang X, Li N, et al.: Effects of salt substitute on pulse wave analysis among individuals at high cardiovascular risk in rural China: a randomized controlled trial. Hypertens Res Clin Exp. 2009; 32:282-. / This article provided the only data that a salt subsititute can also decrease blood vessel stiffness besides effectively reducing blood pressure. CrossRef
  34. Li N, Prescott J, Wu Y, et al. The effects of a reduced-sodium, high-potassium salt substitute on food taste and acceptability in rural northern China. Br J Nutr. 2009;101:1088-3. CrossRef
  35. Chang H-Y, Hu Y-W, Yue C-SJ, et al. Effect of potassium-enriched salt on cardiovascular mortality and medical expenses of elderly men. Am J Clin Nutr. 2006;83:1289-6.
  36. World Health Organisation. Reducing salt intake in populations—Report of a WHO Forum and Technical Meeting. . In: World Health Organisation, ed.; 2007.
  37. Anderson CA, Appel LJ, Okuda N, et al. Dietary sources of sodium in China, Japan, the United Kingdom, and the United States, women and men aged 40 to 59?years: the INTERMAP study. J Am Diet Assoc. 2010;110:736-5. CrossRef
  38. People’s Republic of China—United States Cardiovascular and Cardiopulmonary Epidemiology Research Group. An epidemiological study of cardiovascular and cardiopulmonary disease risk factors in four populations in the People’s Republic of China. Baseline report from the P.R.C.–U.S.A. Collaborative Study. Circulation 1992; 85:1083-6.
  39. Dennis B, Zhou BF, Liu X, et al. Changes in food, nutrient and energy intake in People’s Republic of China samples of urban and rural north and south adults surveyed in 1983-4 and resurveyed in 1987-8. Asia Pac J Clin Nutr. 1997;6:277-6.
  40. He FJ, MacGregor GA. How far should salt intake be reduced? Hypertension. 2003;42:1093-. CrossRef
  41. -Strazzullo P, D’Elia L, Kandala N-B, et al. Salt intake, stroke, and cardiovascular disease: meta-analysis of prospective studies. BMJ. 2009; 339:b4567. / This is the most updated meta-analysis that demonstrates the relationship between salt intake and cardiovascular diseases from prospective studies. CrossRef
  42. ?-Bibbins-Domingo K, Chertow GM, Coxson PG, et al. Projected effect of dietary salt reductions on future cardiovascular disease. N Engl J Med. 2010, 362:590-. / This article provides the most reliable estimates on the cost effectiveness of a population-wide salt-reduction strategy. CrossRef
  43. Staessen JA, Wang JG, Thijs L. Cardiovascular prevention and blood pressure reduction: a quantitative overview updated until 1 March 2003. J Hypertens. 2003;21:1055-6. CrossRef
  44. International Monetary Fund: World Economic Outlook Database-October 2010. Available at: http://en.wikipedia.org/wiki/List_of_countries_by_GDP_(nominal)_per_capita and http://www.imf.org/external/pubs/ft/weo/2010/02/weodata/index.aspx. Accessed December 2010.
  45. Wu Y, Wang Z, Gao R. A survey on perception and knowledge of Chinese health care professionals in prevention and control of hypertension. Chin J Cardiol. 2004;32:264-.
  46. Loria CM, Obarzanek E, Ernst ND. Choose and prepare foods with less salt: dietary advice for all Americans. J Nutr. 2001;131:536S-1.
  47. World Health Organization: Reducing salt intake in populations : report of a WHO forum and technical meeting, 5- October 2006, Paris, France. Available at: World Health Organization Web site www.who.int/dietphysicalactivity/SaltReport-VC-April07.pdf Accessed October 2010.
  48. Application of lower sodium intake recommendations to adults—United States, 1999-006. MMWR Morb Mortal Wkly Rep. 2009; 58:281-.
  49. Chinese Nutrition Society. Meal guide for Chinese residents. Lhasa: People’s Publision House of Tibet; 2008.
  
• 作者单位：Li Yan (1)
  Nicole Li (2)
  Yangfeng Wu (1) (2)
  
  1. Peking University School of Public Health, Beijing, China
  2. The George Institute for Global Health, CHINA Room 1302, Tower B, Horizon Tower, No. 6 Zhichun Rd, Haidian District, Beijing, 100088, People’s Republic of China
  

文摘

This article reviews the best evidence currently available worldwide on the causal relationship between salt intake and blood pressure and its related diseases. The evidence clearly demonstrates that high salt intake causes blood pressure increases and that interventions, either by directly reducing salt intake or by using low-sodium salt substitutes, produce significant reductions in blood pressure, blood vessel stiffness, and cardiovascular mortality. Considering the challenges that China is facing—poor resources but high prevalence of hypertension, a well-coordinated national salt reduction initiative is recommended as a key public health strategy for the prevention and control of hypertension and its related diseases.